Skip To Main Content
Wenying Peng on Muck Rack

Wenying Peng

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Wenying

Contact Wenying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Measurement and improvement strategies of “quantity-quality-flow” comprehensive carrying capacity in the metropolitan fringe: a case of Shunyi District in Beijing, China

|
By Wenying Peng, shuang zhao, Zeyu Chen, Ziyi Shan
| Nature Verified
Abstract The comprehensive urban carrying capacity is related to sustainable urban development, and it affects urban planning and design. Metropolitan fringe is the main area for urban spatial expansion, characterized by frequent factor flow and complex urban-rural relationships. Its comprehensive carrying capacity research is of great significance.
Open in Who Shared Issue with article?

LncRNA HOXB‐AS1 Accelerates Epithelial Ovarian Cancer Progression by Modulating the miR‐671‐5p/SPTBN2 Axis

|
By Wenying Peng, Xiaowen Zhang, Yufei Liang, Xuyue Jia
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request. Supporting Information Filename Description jbt70695-sup-0001-Supplementary_Figure_1.tif451.7 KB Supporting Figure 1: Fer-1 dose-response preliminary experiment results. A. The effects on Fe2+ content changes of different dose of Fer-1. B.
Open in Who Shared Issue with article?

Acquired EGFR L858R mutation following ALK-TKI resistance in lung adenocarcinoma: a case report

|
By Wenying Peng, Runxiang Yang, Susu Qu, Mengyuan Dong, Ruofan Chen, Chunxiang Luo, Ruying Duan
| Frontiers
Abstract Reports of secondary mutations in mutual exclusive driver genes after resistance to targeted therapy are rare. We present a patient with Anaplastic lymphoma kinase (ALK) fusion lung adenocarcinoma who received sequential treatment with ALK tyrosine kinase inhibitor (TKI) (crizotinib, PFS:32.3 months and then conteltinib, PFS: 29 months).
Open in Who Shared Issue with article?
See all 7 articles